CompletedPhase 3

Dexamethasone for Post Uterine Artery Embolization Pain

United States42 participantsStarted 2021-01-25

Plain-language summary

The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, and general feeling of weakness following the procedure.

Who can participate

Age range20 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who meet criteria to undergo uterine fibroid embolization for symptomatic fibroids. Exclusion Criteria: * Currently pregnant or actively attempting to conceive * Those deemed mentally impaired to make their own medical decisions * Previous documented allergy to dexamethasone * Those currently taking daily steroids for any reason * Those with diabetes or deemed to be pre-diabetic * Those with contraindications for angiography * Prisoners

What they're measuring

Pain Scores Using the VAS Questionnaire

Timeframe: Day 7

Trial details

NCT IDNCT04655144

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-04

Results submitted2025-05-24

View on ClinicalTrials.gov More Leiomyoma trials